• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Ray Bailey, RPh: Complexities With Biosimilars


Ray Bailey, RPh, Pharmacy Director at Florida Cancer Specialists, discusses the complexities of biosimilars.


What is your practice’s experience with biosimilars?

I am involved, and yes, there will be an uptake of biosimilars in my practice, I’m sure. We’re talking to those companies. There are some complexities around, you know, reimbursement, so—we’ll kind of just have to wait and see. But I think we’re looking forward to more and more biosimilars coming to market. With us being in all these value-based contracts, I’m sure it’s going to come into play in the way our practice sets up our formularies and pathways.

Related Videos
Lakesha Farmer, PharmD
Lakesha Farmer from Cencora
Jeffrey Casberg, RPh, MS.
Adam Colborn, JD.
Legal scale weighs profit as greater than medical treatment
Ha Kung Wong, JD.
Ha Kung Wong, JD
Cencora's Corey Ford
Related Content
© 2024 MJH Life Sciences

All rights reserved.